The SITC posters will be available on ImCheck's corporate website after the poster sessions have been opened.

The University of Texas MD Anderson Cancer Center's Research Highlights showcases the latest breakthroughs in cancer care, ...

Amtagvi Infusions: A total of 146 patients have been infused with Amtagvi since the first commercial infusion in April 2024, including 25 patients infused in the second quarter, 82 patients infused in ...

Interim data from ongoing Phase 1 clinical trial of WTX-330, further characterizing tolerability and activity profile, to be presented at SITC Annual Meeting – – Monotherapy and combination expansion ...

Mei Wei, MD, an oncologist specializing in breast cancer at Huntsman Cancer Institute at the University of Utah, discusses new treatments for HR+/HER2- breast cancer and immunotherapy challenges, ...

In a report released today, Emily Bodnar from H.C. Wainwright maintained a Buy rating on IO Biotech (IOBT – Research Report), with a ...

PharmaJet ®, a company that strives to improve the performance and outcomes of injectables with its enabling needle-free ...

Two Chinese technology firms involved in the development of pharmaceutical drugs have clinched partnership agreements in ...

Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, today announced groundbreaking research findings demonstrating the potential of its AI to ...

They're metastatic from other sites, melanoma is a top priority because it does share ... patients with glioblastoma treated ...

Despite the potential in oncology, BNTX's current valuation is high relative to its non-COVID revenue prospects, warranting a ...